EUVIMED · CrossrefZeitschrift
Pharmaceutical Statistics
ISSN 1539-1604 · Wiley
Neueste Artikel
Evaluating Early‐Stage Oncology Clinical Trial Designs in the Era of Project Optimus: A Scoping Review
Inverse Probability of Censoring Weights for Single and Competing Events Survival Analyses With Dependent Censoring
Estimation Following Surrogate Based Selection in Multi‐Arm Drop‐The‐Losers Designs
Estimands for Randomized Discontinuation Designs in Oncology
Advancing Drug Development Through Bayesian Approaches: Insights Drawn From Practical Experience in Pharmaceutical R&D
A New Optimal Cut‐Points Selection Method for Diseases With Multiple Ordinal Stages and Its Confidence Interval Estimation
CUI ‐ MET : A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple‐Dose, Multiple‐Outcome Randomized Trials
Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model
Predictive Biomarker Graphical Approach ( PRIME ) for Precision Medicine
Leveraging Two‐Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models
Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
Robust Modestly Weighted Log‐Rank Tests
Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application
Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
Design Considerations for a Phase II Platform Trial in Major Depressive Disorder
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
Statistical Tutorial for Cut‐Point Determination in Immunogenicity Studies
Pre‐Posterior Distributions in Drug Development and Their Properties
WATCH : A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
Tutorial on Firth's Logistic Regression Models for Biomarkers in Preclinical Space
Mixture Experimentation in Pharmaceutical Formulations: A Tutorial
Principles for Defining Estimands in Clinical Trials—A Proposal
Visualizing hypothesis tests in survival analysis under anticipated delayed effects
Current developments of the estimand concept
Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved
Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian Copula
A Personalized Dose‐Finding Algorithm Based on Adaptive Gaussian Process Regression
Applying the Estimand Framework to Non‐Inferiority Trials
On sample size calculation in drug interaction trials
Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomes
EUVIMED